(TB_ART) The number of HIV-positive new and relapsed TB cases on ART during TB treatment

Export Indicator

The number of HIV-positive new and relapsed TB cases on ART during TB treatment
What it measures

This indicator will measure the extent to which programs effectively link HIV-infected TB patients to appropriate HIV treatment. The HIV status of TB patients is often determined at the TB clinics (and will be captured with TB_STAT), but ART for TB cases is frequently provided by the HIV program. Therefore provision of ART for this population often implies successful linkage between the TB and HIV program, which should be followed from TB_STAT_POS to TB_ART.

Numerator

Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period

Calculation

Sum numerator across both reporting periods.

Method of measurement

The numerator is generated by counting the total number of TB patients (new and relapse TB cases) with documented HIV-positive status during TB treatment who are newly initiated or already on ART.

How to review for data quality:

Only one disaggregation type is used for age/sex. Numerator ≥ subtotal of each of the disaggregation.

Reporting Level

Site level, facility only

Measurement frequency

Report 6 months of results at Q2 and Q4 (Semi-Annually).

Disaggregation

Numerator (Required): Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period

Age/sex (Required)

<1, 1-9, 10-14 M, 10- 14 F, 15-19 M, 15-19 F, 20-24 M, 20-24 F, 25-49 M, 25-49 F, 50+ M, 50+ F

Age/Sex (Coarse Disaggregate)(Conditional)

<15 M, 15+ M, <15 F, 15+F

Current/New on ART (Required)

Currently on ART; New on ART

Description of Disaggregate

Age is defined as the age at the date of initiation on ART or current age, not the age at the date of reporting.

This disaggregation should only be entered if finer age disaggregates are not available.

This disaggregation should distinguish those who started ART during the reporting period (this should also be reported under TX_NEW) from those who were already on it at the beginning of the reporting period.

 

Further information

MER 1.0 to 2.0 Change

Indicator revised with the following:

1. Denominator was removed

2. HIV treatment disaggregate revised to be already on ART/new on ART.

3. Finer Age/Sex disaggregates aligned across clinical cascade

4. Timing of ART (<8 weeks etc.) removed

PEPFAR Support definition

Provision of key staff or commodities for TB cases receiving HIV-related services include: ongoing provision of critical re-occurring costs or commodities (such as ARVs) or funding of salaries or provision of Health Care Workers for TB/HIV clinic services. Where TB and HIV services are not integrated, this can include support for system/personnel critical to patient referral, transfer or tracking that ensures patient linkage between the TB and HIV programs/facilities that is required to accomplish the delivery of the service. Staff responsible for maintaining patient records are included in this category however staff responsible for fulfilling reporting and routine M&E requirements are not included.

Ongoing support for TB cases receiving HIV-related services includes: Clinical mentoring and supportive supervision of staff at ART sites, Quality Improvement services support, patient tracking/referral system support, routine support of ART M&E and reporting, commodities consumption forecasting and supply management.

DREAMS SNU Specific Guidance

None